A single exposure of adult C57BL/6 mice to 400 r total-body X-irradiation yielded 5% leukemia; thymectomy reduced the incidence to zero, while subsequent implantation of normal thy mus reversed the process. Subsequent urethan treatment raised the incidence in nonthymectomized, irradiated mice to 34% and in thymectomized, irradiated, and thymus-implanted mice to 17 %. When the thymus implant was given after instead of before the urethan treatment, the leukemia incidence remained low (4%). These results confirm in adults, what had previously been found in newborn mice, that thymus implantation cannot restore urethan leukemogenesis in thymectomized mice, as it does in the case of radiation leukemogenesis.
Introduction
The fact that leukemogenesis (thymic lymphosarcoma induc tion) in C57BL mice by fractional total-body X-irradiation is prevented by prior thymectomy (8) , and rendered effective again by subsequent implantation of nonirradiated syngeneic newborn thymus (10) , is generally accepted as evidence that the leukemogenic action of X-irradiation on the thymus is able to operate in an indirect way (5) .
Urethan leukemogenesis differs from radiation leukemogenesis in many respects. When, for instance, the technic of thymectomy followed by reimplantation of normal thymus was applied to urethan leukemogenesis in newborn C57BL mice (1), the reversal effect by the reimplantation was not observed. [The use of new born mice was necessitated by the fact that urethan, acting alone, is very weakly leukemogenic to adult C57BL mice (1) but fairly effective when the treatment is begun soon after birth (1, 6, 7, 12) .] A plausible explanation of the failure of thymus reimplanta tion to reverse the inhibition of thymectomy in the case of ure than was that, unlike radiation leukemogenesis, urethan leu kemogenesis operates directly on the thymus (1) .
In the present investigation, advantage was taken of the fact that urethan can potentiate radiation leukemogenesis in adult C57BL miceâ€"aneffect observed not only when the 2 treatments are given concurrently (11) but also when the urethan treatment is begun 2 weeks after completion of the radiation treatment, though not when the sequence is reversed (2) . Using this system for testing the influence of thymectomy and reimplantation of 'The work was supported by Research Grant CA-05455, The National Cancer Institute, USPHS.
Received for publication November 26, 1965. normal thymus, it was possible not only to test in adults the validity of the observation made in newborn mice, but also to check, in the same experiment, the effect of thymus reimplanta tion separately on the radiation component and on the urethan component of the 2-stage leukemogenic action (i.e., on the as sumption that, under such conditions, a single dose of radiation acts mainly as initiator and the subsequent urethan treatment as promoter).
Materials and Methods
The animals used were C57BL/6 mice, original!}' derived from a pair obtained from the Jackson Laboratories, Bar Harbor, Maine, and since bred here by brother-sister mating. They were kept in stainless steel cages, bedded with sawdust, housed in an air-conditioned room at 21-25Â°C, fed Purina Laboratory Chow, occasionally supplemented with barley and sunflower seeds, and provided with water ad libitum.
Mice of both sexes were thymectomized when 5-6 weeks old, and 2 weeks later, submitted to a single exposure of 400 r totalbody X-irradiation. (Physical conditions for radiation: 250 kv, 15 ma, with 1 mm Al and 0.5 mm Cu filters; at a dose rate of 67 r/ min) After an interval of 1-2 hr, each animal was grafted with a thymus from a newborn mouse of the same strain, either s.c. (Group V) or under the kidney capsule (Group VI). Two weeks later, urethan treatment was begun, consisting of 10 weekly, i.p. injections of a 10% aqueous solution, the dose per injection being 1 mg/gm body weight. In Group IX, the order was changed: the thymectomized and irradiated mice were 1st given the course of s.c. urethan injections and then grafted with a newborn thymus.
The controls included: (a) nonthymectomized, irradiated mice receiving urethan injections (Group I); (b) nonthymectomized mice receiving irradiation only (Group II); (c) thymectomized and irradiated mice without urethan treatment or thymus reim plantation (Group III); (d) thymectomized and irradiated mice receiving s.c. thymus graft, without urethan treatment (Group IV) ; (e) similar to Group IV, but with the grafting performed 2 months later (Group VIII), to serve as control for experimental Group IX; and (/) thymectomized and irradiated mice receiving urethan treatment, but without reimplantation of thymus (Group VII).
The mice were examined every 2 weeks for signs of leukemia or, in the case of the grafted animals, for enlargement of the thymic implants. Those showing changes suggestive of leukemia were killed and autopsied and the affected tissue kept for histologie examination. Mice that died before the 21st week (the time of the 1st appearance of leukemia) or those with thymic remnants at the original site of the thymectomized animal*, were not included in the evaluation of the results. The experiment was terminated 66 weeks after the irradiation and all surviving animals killed and autopsied.
Results
In Table 1 , summarizing the results of the experiment, the lesions produced are listed under 2 major categories: (a) lym phatic leukemiaÂ«and/or lymphosarcomas, and (6) other leu kemias, includili};;myeloid leukemia and reticulum-cell sarcomas. In view of the element of doubt as to whether the leukemias in the 2nd group arise as the consequence of the treatment given or whether they are spontaneous in origin, only the lymphatic group is considered here in evaluating the influence of the experimental treatment.
In the unoperated controls (i.e., without thymectomy and reimplantation of thymus), the leukemia incidence was 5% follow ing a single exposure of 400 r (Group II) and 34% when this treatment was followed by repeated injections of urethan (Group I). Thymectomy prior to irradiation reduced the incidence to zero (Group III), and this was not altered by subsequent ad ministration of urethan (Group VII). When the thymectomized and irradiated mice were given a transplant of normal newborn thymus, the incidence was raised from 0 to 3% (Group IV), but remained 0 when the transplant was given 2 months later (Group VIII). When the thymectomized and irradiated mice received a thymus implant either s.c. or under the kidney capsule and were then given urethan treatment (Groups V and VI), the leukemia incidence was raised to 17 and 18% respectively, in striking con trast to the case (Group IX) where the thymectomized and irradi ated mice were 1st given urethan treatment and then implanta tion of a thymus graft. The significance of the difference between the results of Groups V and IX, by the x2 test, was P = <0.05.
Discussion
The low incidence of leukemia following a single irradiation of 400 r (5%) is in keeping with the earlier finding (4, 9) that radia tion leukemogenesis in mice is far less effective when the irradia tion is given as a single dose than in divided doses ; while the aug mentation by subsequent urethan treatment (to 34%) confirms our earlier results that the role of urethan is not merely additiveâ€" urethan alone eliciting 2-6% leukemia under similar conditions (1, 3)â€"but more in keeping with a 2-stage process of initiation and promotion (2) .
The crucial results of this experiment are concerned with the groups of mice receiving all 4 treatmentsâ€"thymectomy, Xirradiation, reimplantation of thymus, and urethan treatmentâ€" with the thymus reimplantation performed before or after the urethan treatment (i.e., Groups V and IX). The fact that the former yielded 17% leukemia while the latter only 4%, shows that the reimplantation was only effective on the radiation com ponent of the radiation-urethan 2-stage process of leukemoge nesis. The possible influence of reimplantation of thymus, in the case of Group IX, could only be considered in relation to the urethan component, since the long interval after the radiation rendered it ineffective in relation to the radiation component (cf. control Group VIII). The observed 4% leukemia incidence in Group IX would seem to be a simple urethan effect and not a reversal to the radiation-urethan synergism.
These results are in keeping with those reported in newborn mice treated with urethan alone (1), and provide more satisfac tory evidence that while reimplantation of normal thymus re verses, to a large extent, the inhibiting effect of thymectomy in the case of radiation leukemogenesis, it does not do so in the case of urethan leukemogenesis. This supports the view that whereas radiation leukemogenesis can operate indirectly on the thymus, the urethan action is probably directly on that organ (1 
